Cargando…
The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies
Recent advances in genomic medicine have led to the availability of genomic tests that have the potential to improve population health, yet the process for obtaining these tests and getting them reimbursed by insurers has not been described. The objective of this study was to describe the process of...
Autores principales: | Wu, Ann Chen, Mazor, Kathleen M., Ceccarelli, Rachel, Loomer, Stephanie, Lu, Christine Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313431/ https://www.ncbi.nlm.nih.gov/pubmed/30275409 http://dx.doi.org/10.3390/jpm8040032 |
Ejemplares similares
-
Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients
por: Wu, Ann Chen, et al.
Publicado: (2017) -
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer
por: Lu, Christine Y., et al.
Publicado: (2018) -
Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
por: Kim, Jeeyun A., et al.
Publicado: (2021) -
Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
por: Hippman, Catriona, et al.
Publicado: (2019) -
Pharmacogenomic testing in paediatrics: Clinical implementation strategies
por: Barker, Charlotte I. S., et al.
Publicado: (2022)